In thyroid cancer, MAPKAPK5-AS1 facilitated cell malignancy by upregulating YWHAH through adsorbing miR-519e-5p, highlighting the oncogenic role of YWHAH [25]. Here, MAPKAPK5 is linked to thyroid gland carcinoma.